We are live on
!
Find out more
AFM
Abbot Financial Management Portfolio holdings
AUM
$239M
1-Year Est. Return
27.19%
This Fund
S&P 500
This Quarter
Est. Return
+4.86%
1 Year Est. Return
+27.19%
3 Year Est. Return
+80.47%
5 Year Est. Return
+79.47%
10 Year Est. Return
–
AUM
$229M
AUM Growth
+$8.37M
(+3.8%)
Cap. Flow
-$289K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
40%
Holding
135
New
2
Increased
36
Reduced
51
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iron Mountain
IRM
|
+$256K |
| 2 |
TSMC
TSM
|
+$211K |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$162K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156K |
| 5 |
Mercado Libre
MELI
|
+$88.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$208K |
| 2 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
+$208K |
| 3 |
Carrier Global
CARR
|
+$202K |
| 4 |
Moderna
MRNA
|
+$131K |
| 5 |
Merck
MRK
|
+$111K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.89% |
| 2 | Technology | 18.55% |
| 3 | Financials | 10.75% |
| 4 | Consumer Discretionary | 7.21% |
| 5 | Industrials | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
| $34.5M | 15.06% |
1,411,775
-2,725
| -0.2% | -$68.2K |
|
2
Microsoft
MSFT
$2.9T
| $12.5M | 5.44% |
45,974
-128
| -0.3% | -$32.5K |
|
3
Apple
AAPL
$4.97T
| $9.56M | 4.18% |
69,779
-99
| -0.1% | -$12.8K |
|
4
JPMorgan Chase
JPM
$916B
| $6.41M | 2.8% |
41,181
+160
| +0.4% | +$25.1K |
|
5
Nike
NKE
$64.1B
| $5.57M | 2.44% |
36,060
+52
| +0.1% | +$7K |
|
6
Bank of America
BAC
$429B
| $5.06M | 2.21% |
122,703
-1,229
| -1% | -$50.4K |
|
7
Vanguard Morningstar Growth ETF
VUG
$212B
| $4.84M | 2.12% |
101,250
-114
| -0.1% | -$5.18K |
|
8
Alphabet (Google) Class A
GOOGL
$4.12T
| $4.75M | 2.08% |
38,880
-520
| -1% | -$60.7K |
|
9
Intel
INTC
$413B
| $4.41M | 1.93% |
78,465
-214
| -0.3% | -$12.6K |
|
10
Cisco
CSCO
$443B
| $4.01M | 1.75% |
75,735
-319
| -0.4% | -$16.8K |
|
11
Walt Disney
DIS
$171B
| $3.98M | 1.74% |
22,651
+169
| +0.8% | +$30.4K |
|
12
State Street Technology Select Sector SPDR ETF
XLK
$109B
| $3.68M | 1.61% |
49,904
-1,240
| -2% | -$86.9K |
|
13
Johnson & Johnson
JNJ
$640B
| $3.54M | 1.55% |
21,501
-449
| -2% | -$74.3K |
|
|
14
iShares Russell 2000 ETF
IWM
$79.1B
| $3.41M | 1.49% |
14,875
+720
| +5% | +$162K |
|
15
Home Depot
HD
$337B
| $3.38M | 1.48% |
10,611
-58
| -0.5% | -$18.4K |
|
16
Vanguard Morningstar Mid-Cap ETF
VO
$106B
| $3.2M | 1.4% |
53,944
-476
| -0.9% | -$27.6K |
|
17
Procter & Gamble
PG
$340B
| $3.09M | 1.35% |
22,929
-99
| -0.4% | -$13.4K |
|
18
Amazon
AMZN
$2.44T
| $3.03M | 1.32% |
17,620
-120
| -0.7% | -$19.9K |
|
19
PepsiCo
PEP
$196B
| $3.02M | 1.32% |
20,352
-119
| -0.6% | -$17.3K |
|
|
20
Merck
MRK
$322B
| $2.86M | 1.25% |
36,723
-1,497
| -4% | -$111K |
|
21
Vanguard Dividend Appreciation ETF
VIG
$111B
| $2.84M | 1.24% |
18,376
+138
| +0.8% | +$21.2K |
|
22
McDonald's
MCD
$193B
| $2.77M | 1.21% |
12,003
-164
| -1% | -$38.2K |
|
23
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
| $2.73M | 1.19% |
74,442
+1,144
| +2% | +$41.8K |
|
24
Blackstone
BX
$104B
| $2.67M | 1.17% |
27,466
-146
| -0.5% | -$13K |
|
25
Lockheed Martin
LMT
$131B
| $2.65M | 1.16% |
6,997
+16
| +0.2% | +$6.15K |
|
Similar funds
HC
CWM
SP
I2I
IIM
MMM
M
FWP
Abbot Financial Management's Q2 2021 Portfolio in Review
As of Q2 2021, Abbot Financial Management held 135 positions worth $229M, up 3.8% from $220M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Trading was light in Q2 2021: portfolio turnover was 3.7%. Abbot Financial Management opened 2 new positions and exited 3, leaving the 135-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Financials.
- Abbot Financial Management's largest Q2 2021 buy was Iron Mountain: 6,100 shares worth $258K.
- Abbot Financial Management added most to iShares Russell 2000 ETF in Q2 2021, an estimated $162K increase.
- Abbot Financial Management's biggest Q2 2021 reduction was Moderna, cutting an estimated $131K.
- Abbot Financial Management fully exited G1 Therapeutics, Inc. Common Stock in Q2 2021, selling an estimated $208K.
- Abbot Financial Management's ten largest holdings make up 40% of its $229M portfolio in Q2 2021.
- Abbot Financial Management opened 2 new positions and closed 3 in Q2 2021.
- Abbot Financial Management's portfolio value rose 3.8% quarter-over-quarter to $229M.
Based on Abbot Financial Management's 13F filing for Q2 2021, filed 5 Aug 2021.